Group One Trading’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,000
| Closed | -$6K | – | 5926 |
|
|
2019
Q2 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 4590 |
|
|
2019
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 4426 |
|
|
2018
Q4 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 4418 |
|
|
2018
Q3 | $8K | Sell |
1,000
-500
| -33% | -$3.61K | ﹤0.01% | 4737 |
|
|
2018
Q2 | $11K | Buy |
+1,500
| New | +$11.8K | ﹤0.01% | 4610 |
|
|
2018
Q1 | – | Sell |
-26,300
| Closed | -$207K | – | 5759 |
|
|
2017
Q4 | $207K | Buy |
26,300
+1,300
| +5% | +$9.73K | ﹤0.01% | 2907 |
|
|
2017
Q3 | $176K | Sell |
25,000
-2,300
| -8% | -$15.7K | ﹤0.01% | 2854 |
|
|
2017
Q2 | $184K | Buy |
27,300
+25,300
| +1,265% | +$139K | ﹤0.01% | 2700 |
|
|
2017
Q1 | $11K | Buy |
+2,000
| New | +$11.6K | ﹤0.01% | 4108 |
|
|
2016
Q3 | – | Sell |
-20,000
| Closed | -$119K | – | 5411 |
|
|
2016
Q2 | $119K | Hold |
20,000
| – | – | ﹤0.01% | 2746 |
|
|
2016
Q1 | $128K | Buy |
20,000
+19,900
| +19,900% | +$119K | ﹤0.01% | 2660 |
|
|
2015
Q4 | $1K | Sell |
100
-2,000
| -95% | -$10.8K | ﹤0.01% | 4675 |
|
|
2015
Q3 | $11K | Buy |
2,100
+100
| +5% | +$530 | ﹤0.01% | 4289 |
|
|
2015
Q2 | $11K | Buy |
+2,000
| New | +$10.6K | ﹤0.01% | 4277 |
|
|
2015
Q1 | – | Sell |
-12,500
| Closed | -$65K | – | 5782 |
|
|
2014
Q4 | $65K | Buy |
12,500
+1,000
| +9% | +$5.1K | ﹤0.01% | 3189 |
|
|
2014
Q3 | $55K | Buy |
11,500
+10,100
| +721% | +$54.2K | ﹤0.01% | 3463 |
|
|
2014
Q2 | $8K | Sell |
1,400
-4,300
| -75% | -$26.1K | ﹤0.01% | 4636 |
|
|
2014
Q1 | $41K | Sell |
5,700
-13,000
| -70% | -$86.1K | ﹤0.01% | 3781 |
|
|
2013
Q4 | $114K | Sell |
18,700
-10,200
| -35% | -$61.5K | ﹤0.01% | 2918 |
|
|
2013
Q3 | $173K | Buy |
28,900
+17,100
| +145% | +$81.7K | ﹤0.01% | 2507 |
|
|
2013
Q2 | $46K | Buy |
+11,800
| New | +$43.9K | ﹤0.01% | 3515 |
|
Other funds holding SVA
Group One Trading's SVA Position: Q3 2024 in Review
Group One Trading sold out of Sinovac Biotech, Ltd (SVA) in Q3 2024, closing a stake of 412 shares — an estimated $2.67K sold.
Group One Trading first reported a position in SVA in Q2 2013 and held it in 38 quarters. The position peaked at $220K in Q3 2017. 9 funds tracked by Wall St. Rank hold SVA as of Q3 2024.
- Group One Trading reported no remaining Sinovac Biotech, Ltd position as of Q3 2024 after selling out during the quarter.
- Group One Trading sold 412 Sinovac Biotech, Ltd shares in Q3 2024, an estimated $2.67K.
- Group One Trading first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 38 quarters.
- Group One Trading's Sinovac Biotech, Ltd position peaked at $220K in Q3 2017.
- 9 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q3 2024.
Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.